Exploratory Study of the Cutaneous Penetration of Biodegradable Polymeric Microparticles in Atopic Dermatitis (MicroIskin)
Sponsor: Centre Hospitalier Universitaire de Besancon
Terminated
Difficulties in enrolling patients
Other terminated trials from Centre Hospitalier Universitaire de Besancon
- Metastatic Colorectal Cancer · Phase PHASE2 · Nov 2024
- Gallstone · Phase NA · Sep 2024
- Children, Only · Phase NA · Apr 2024
- Mandibular Dysfunction · Phase NA · Feb 2024
- Metastatic Pancreatic Adenocarcinoma · Phase PHASE2 · Feb 2024
See all terminations from Centre Hospitalier Universitaire de Besancon
Listed as NCT02369432, this EARLY_PHASE1 trial focuses on Atopic Dermatitis and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire de Besancon, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Terminated EARLY_PHASE1
-
Oct 2017 — Jun 2018 [monthly]
Terminated EARLY_PHASE1
Status: Recruiting → Terminated
▶ Show 2 earlier versions
-
Feb 2017 — Oct 2017 [monthly]
Recruiting EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting Phase 0
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Besancon
- University of Franche-Comté
For direct contact, visit the study record on ClinicalTrials.gov .